1-2 of 2
Xuelin Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML

Open Access
Clinical Trials & Observations
Patricia L. Kropf, Woonbok Chung, Raji Shameem, Lianchun Xiao, Curt Balch, Xuelin Huang, Jean-Pierre J. Issa
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (2): 100071.
https://doi.org/10.1016/j.bneo.2025.100071
Published: 2025
Includes: Supplemental data
Journal Articles

Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMML

Free
Samuel Urrutia, Prithviraj Bose, Yesid Alvarado, Gautam Borthakur, Farhad Ravandi, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Koichi Takahashi, Tapan Kadia, Courtney DiNardo, Steven Kornblau, Rashmi Kanagal-Shamanna, Xuelin Huang, Kristy Bodden, Hagop Kantarjian, Guillermo Garcia-Manero
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (2): 100008.
https://doi.org/10.1016/j.bneo.2024.100008
Published: 2024
Includes: Supplemental data